Caricamento...
Annexin A2 is an independent prognostic biomarker for evaluating the malignant progression of laryngeal cancer
Due to the lack of a definite diagnosis, a frequent recurrence rate and resistance to chemotherapy or radiotherapy, the clinical outcome for patients with advanced laryngeal cancer has not improved over the last decade. Annexin A2 is associated with the invasion and metastasis of cancer cells. In th...
Salvato in:
| Pubblicato in: | Exp Ther Med |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
D.A. Spandidos
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5740805/ https://ncbi.nlm.nih.gov/pubmed/29285166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2017.5298 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|